Engineering DYRK1A overdosage yields Down syndrome-characteristic cortical splicing aberrations
- 31 October 2010
- journal article
- Published by Elsevier BV in Neurobiology of Disease
- Vol. 40 (1), 348-359
- https://doi.org/10.1016/j.nbd.2010.06.011
Abstract
No abstract availableKeywords
This publication has 66 references indexed in Scilit:
- Increased Dosage of Dyrk1A Alters Alternative Splicing Factor (ASF)-regulated Alternative Splicing of Tau in Down SyndromePublished by Elsevier BV ,2008
- Targeting Dyrk1A with AAVshRNA Attenuates Motor Alterations in TgDyrk1A, a Mouse Model of Down SyndromeAmerican Journal of Human Genetics, 2008
- Overexpression of Dyrk1A contributes to neurofibrillary degeneration in Down syndromeThe FASEB Journal, 2008
- Neuronal regulation of alternative pre-mRNA splicingNature Reviews Neuroscience, 2007
- Splicing in disease: disruption of the splicing code and the decoding machineryNature Reviews Genetics, 2007
- Splicing Regulation in Neurologic DiseaseNeuron, 2006
- Butyrylcholinesterase attenuates amyloid fibril formation in vitroProceedings of the National Academy of Sciences of the United States of America, 2006
- NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21Nature, 2006
- Nova regulates brain-specific splicing to shape the synapseNature Genetics, 2005
- Nuclear speckles: a model for nuclear organellesNature Reviews Molecular Cell Biology, 2003